Prediction of Outcome for Patients with Cutaneous Melanoma

Pigment Cell Research

Volumn 10, Issue 3, 1997, Pages 162-167

  Cochran, Alistair J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical features; Histology; Melanoma; Molecular biology; Prognosis

Indexed keywords

COLORING AGENT; TUMOR MARKER;

CANCER INVASION; CANCER STAGING; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MORTALITY; PATHOLOGY; REVIEW; RISK; SKIN TUMOR; TREATMENT OUTCOME; TUMOR EMBOLISM;

COLORING AGENTS; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; RISK; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0031158062     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.1997.tb00479.x     Document Type: Review

References (30)

1. Allen, A.C. and S. Spitz (1953) Malignant melanoma: A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer, 6:1-45.
2. Bailly, M. and J.F. Doré (1991) Human tumor spontaneous metastases in immuno suppressed newborn rates. II. Multiple selections of human melanoma metastatic clones and variants. Int. J. Cancer, 49:750-757.
3. Balch, C.M., J.A. Wilkerson, T.M. Murad, D.J. Soong, A.L. Ingalls, and W.A. Maddox (1980) The prognostic significance of ulceration of cutaneous melanoma. Cancer, 45:3012-3017.
4. Berthier-Vergnes, O., N. Zebda, M.Bailly, C. Bailly, J.F. Doré, L. Thomas, and A.J. Cochran (1993) Expression of Arachis Hypogea (peanut agglutinin)-binding conjugates occurs selectively in primary melanomas with a high risk of metastases. Lancet, 341:1292.
5. Breslow, A. (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172:902-908.
6. Carson, K.F., D.-R. Wen, A.M.A. Lana, P.-X. Li, and A.J. Cochran (1996) Nodal nevi, frequency and mechanism of formation. Am. J. Surg. Pathol. 20:834-840.
7. Chen, Z.-L., D.-R. Wen, W.F. Coulson, A.E. Giuliano, and A.J. Coehran (1991) Occult metastases in the axillary lymph nodes of patients with breast cancer node-negative by clinical and histologie examination and conventional histology. Disease Markers, 9:239-248.
8. Chen, Z.-L., E.C. Holmes, W.F. Coulson, S. Perez, H.J. Wang, D.-R. Wen, and A.J. Coehran (1993) The frequency and distribution of occult micrometastasea in lymph nodes of patients with non-small cell lung cancer. J. Natl. Cancer Inst, 85:493-498.
9. Clark, W.J., Jr. (1967) A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Advances in the Biology of the Skin. W Montagna and F. Hu, eds. Pergammon Press, New York, 8:621-647.
10. Clark, WH., Jr., D.E. Elder, D. Guerry, IV, L.E. Braitman, B.J. Trock, D. Schultz, M. Synnestvedt, and A.C. Halpern (1989) Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst., 81:1893-1904.
11. Cochran, A.J. (1968) Method of assessing prognosis in patients with malignant melanoma. Lancet 2:1062-1064.
12. Cochran, A.J. (1969) Histology and prognosis in malignant melanoma. J. Pathol., 97:459-468.
13. Cochran, A.J., D.-R. Wen, and D.L. Morton (1988) Occult tumor cells in the lymph nodes of patients with pathological Stage I malignant melanoma. Am. J. Surg. Pathol., 12:612-618.
14. Cochran, A.J., Wen, D-R, Herschman, Jr. (1984) Occult melanoma in lymph nodes detected by an antiserum to S-100 protein. Int. J. Cancer 34:159-163.
15. Cochran. A.J., C. Bailly, E. Paul, and F. Remotti (1997) Characteristics that relate to prognosis. In: Melanocytic Tumors: A Guide to Diagnosis. Lippincott-Raven, Philadelphia, pp. 261-286.
16. Doré, J.F., O. Berthier-Vergnes, N. Zebda, M. Bailly, L. Thomas, C. Bailly, and A.J. Cochran (1994) Selective expression of PNA-binding glycoconjugates by invasive human melanomas: A new marker of metastatic potential. Pigment Cell Res., 7:461-464.
17. Hoon, D.S.B, Y. Wang, P.S. Dale, A.J. Conrad, P. Schmid, D. Garrison, C. Kuo, L.J. Foshag, A.J. Nizze, and D.L. Morton (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13:2109-2116.
18. Larsen, T.E. and T.H. Grude (1979) A retrospective study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. Acta Pathol. Microbiol. Scand., 87:131-138 (Sect A).
19. Li, P-X., L.C. Cheng, D.-R. Wen, P. Wissman, J. Cheng, W.W. Grody, and A.J. Cochran (1997) Demonstration of cytoplasmic tyrosinase in RNA in tissue cultured cells by RT in situ PCR and PCR in situ hybridization. Diagn. Molec. Pathol., X:X-X.
20. Little, J.H. (1972) Histology and prognosis in cutaneous malignant melanoma. In: Melanoma and Skin Cancer. W.H. McCarthy, ed. VCN Blight, Government Printer, Sydney, pp. 107-110.
21. MacKie, R.M., D.C. Carfrae and A.J. Cochran (1972) The assessment of prognosis in patients with malignant melanoma. Lancet 2:456-458.
22. MacKie, R.M., T. Aitchison, J.M. Sirel, K. McLaren, and D.C. Watt (1995) Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. Br. J. Cancer, 71:173-176.
23. McGovern, V.J., H.M. Shaw, G.W. Milton, and G.A. Garago (1980) Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? Histopathology 4:235-242.
24. Morton, D.L., D.-R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, F.K. Storm, L.J. Foshag, and A.J. Cochran (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg., 127:392-399.
25. Sagebiel, R.W. (1994) The pathology of melanoma as a basis for prognostic models: The UCSF experience. Pigment Cell Res., 7:101-103.
26. Schmoeckel, C., A. Brockelbrink, H. Brockelbrink, J. Koutsis, and O. Braun-Falco (1993) Low- and high risk-malignant melanoma. I. Evaluation of clinical and histological prognosticators in 585 cases. Eur. J. Cancer Clin. Oneol., 19:227-232.
27. Schuchter, L., D.J. Sehultz, M. Synnestvedt, B.J. Trock, D. Guerry, d.E. Elder, R. Elenitsas, W.H. Clark, and A.C. Halpern (1996) A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann. Intern. Med., 125:369-375.
28. Shaw, H.M., S.W. McCarthy, W.H. McCarthy, J.F. Thompson, and G.W. Milton (1989) Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases. Histopathology, 15:257-265.
29. Smith, B., P. Selby, J. Southgate, K. Pittman, C. Bradley, and G.E. Blair (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229.
30. Wang, X., R. Heller, N. Van Voorhis, C.W. Cruse, F. Glass, N. Fenske, C. Berman, J. Leo-Messina, D. Rappaport, K. Wells, R. DeConti, L. Moscinski, C. Stankard, C. Puleo, and D. Reintgen (1994) Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann. Surg., 220:768-774.